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Tetrabromobisphenol A (TBBPA) is one of the most widely used members of the family of brominated flame retardants (BFRs). BFRs, including
TBBPA have been shown to bewidely distributed within the environment and there is growing evidence of their bio-accumulation within animals and
man. Toxicological studies have shown that TBBPA can be harmful to cells by modulating a number of cell signalling processes. In this study, we
employed fluorescence spectroscopy and differential scanning calorimetry to investigate the interaction of TBBPAwith phospholipid membranes, as
this is the most likely route for it to influence membrane-associated cellular processes. TBBPA readily and randomly partitions throughout all regions
of the phospholipid bilayer with high efficacy {partition coefficient (Log Kp)=5.7±0.7}. A decrease in membrane fluidity in both liquid-crystalline
and gel-phase membranes was detected at concentrations of TBBPA as low as 2.5 μM. TBBPA also decreases the phase transition temperature of
dipalmitoyl phoshatidylcholine (DPPC) membranes and broadened transition peaks, in a fashion similar to that for cholesterol. TBBPA, however,
also prefers to partition into membrane regions not too highly enriched with cholesterol. Our findings therefore suggests that, the toxic effects of
TBBPA, may at least in part, be due to its lipid membrane binding/perturbing effects, which in turn, could influence biological processes involving
cell membranes.
© 2007 Elsevier B.V. All rights reserved.Keywords: Brominated flame retardant; Tetrabromobisphenol A; Phospholipid; Membrane fluidity; Fluorescence spectroscopy; Differential scanning calorimetry1. Introduction
Brominated flame retardants (BFRs) are a large group of
commonly used compounds, which are utilized to treat a variety
of everyday items, in order to reduce their risk of combustion
([1]). Currently, one of the most widely used BFRs is
Tetrabromobisphenol A (TBBPA) [1], which is used in the
manufacture of printed circuit boards and as an additive in several
types of polymers such as ABS, polystyrenes and epoxy resins.
These polymers are ultimately used in a variety of consumer
products, including computers, household electronic equipment,
textiles, adhesives, paper, foam furniture and insulating foams,
etc.
Recent reports have shown that BFRs exist in the environ-
ment far from their location of production and/or use; and that
the concentrations of some of the BFRs, both in the environment⁎ Corresponding author. Tel.: +44 121 414 5398; fax: +44 121 414 5925.
E-mail address: F.Michelangeli@Bham.ac.uk (F. Michelangeli).
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doi:10.1016/j.bbamem.2007.03.013and in humans, are rapidly increasing [2]. Concentrations of
various BFRs have been found at levels as high as 1 mg/kg of
dried sewage slurry [3] and up to 160 ng/g (equivalent to
approximately 0.3 μM) in some samples of human serum lipid
[4]. More specifically, TBBPA has been found to be in relatively
high abundance in the air [5], soil and sediment samples [6,7].
Jakobsson et al. [8] also found TBBPA in 80% of the serum
samples from computer technicians, at levels ranging up to
3.4 pmol/g lipid; and in appreciably higher levels in workers
continually exposed to high levels of this chemical, in elec-
tronics dismantling facilities [9].
In-vitro and in-vivo studies have demonstrated the adverse
toxic effects of TBBPA on a number of cell types/tissues in-
cluding the liver, neuronal tissue and neutrophils [10–13].
More recently, the possibility of TBBPA acting as a potential
endocrine disruptor has been of focus due to its similarity to
Bisphenol A, a known environmental estrogen [14]. Studies
investigating a variety of BFRs, including a number of TBBPA
analogues showed that, they exhibited some estrogenic activity
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triiodothyronine (T3) and transthyretin (TTR) binding in the 1–
100 μM concentration range, as well as, enhancing the
proliferation of rat pituitary GH3 cells and stimulating their
ability to produce growth hormone [16]. Furthermore, TBBPA at
a concentration of 1–12 μM has been shown to modulate a
number of cell signalling processes such as the activities of
tyrosine kinases, MAP kinases, protein kinase C; and the levels
of reactive oxygen species and cytosolic Ca2+, when added to
neutrophils [17].
In order for TBBPA to have such profound effects upon cells,
it will need to either interact with, or pass through cell
membranes. Thus, it is important that we have some knowledge
of how TBBPA binds to and interacts with phospholipid bi-
layers, in order for it to affect cellular processes involving
membrane interactions. In this study, we have employed a
variety of fluorescence spectroscopic methods and differential
scanning calorimetry to study the interaction between TBBPA
and phospholipid bilayers. This study specifically focuses on
where and to what degree TBBPA binds within the phospholipid
bilayer and whether it changes the biophysical properties of the
membrane in terms of alteration in fluidity, the phase transition
temperature and ion permeability associated with changes in
lipid packing.
2. Materials and methods
Dioleoyl-phosphatidylcholine (18: 1), DOPC; Dipalmitoyl-phosphatidyl-
choline (16: 0), DPPC; Cholesterol, CHOL; Diphenylhexatriene, DPH; 6-(1-
Pyrenyl) dodecanoic acid, PDA; 6-(1-Pyrenyl) hexanoic acid, PHA; 1, 2-
Dioleyl-sn-glycerol-3- phosphoethanolamine-pyrene-labelled, (pyDOPE); SPM,
sphingomyelin, were purchased from Sigma and Tetrabromobisphenol A
(TBBPA) from Acrôs Organics, UK.
As previously shown, some hydrophobic compounds can preferentially
partition at different locations within the phospholipid bilayer [18]. The binding
position/depth of TBBPA within phospholipid bilayers was therefore investi-
gated employing fluorescence quenching methods as described by Michelangeli
et al. [19,20], since these studies have shown that organo-bromine molecules can
readily quench the fluorescence of pyrene and thus, this has proved to be a useful
method in assessing how brominated molecules like TBBPA, can interact with
membranes containing pyrene-labelled lipids. Pyrene derivatives were chosen
because the fluorescence properties of the pyrene group can be used to quantitate
binding; and to provide information on the nature of the binding sites within the
membrane [18]. Previous studies with the pyrene fatty acid, PDA has shown that
when incorporated into phospholipid bilayers, the complex emission spectra
appears similar to that of PDA dissolved in hydrophobic solvents such as
benzene or isopropyl ether. This would suggest that the pyrene group of PDA is
likely to be located deep within the hydrophobic core of the bilayer (Jones and
Lee [18]). This is further supported by other studies which have shown that PDA
fluorescence is extensively quenched by Brominated DOPC where the bromine
groups are located halfway down the fatty acid chains. Thus, from these studies
it is clear that PDA binds to the fatty-acyl region of phospholipid bilayers with
high affinity (kd<1 μM) [18]. As pyrene fluorophores exhibit excimer
fluorescence when in contact or in close proximity with other pyrene molecules,
this can be used to assess the degree of probe aggregation within the membrane.
The study by Jones and Lee [18], has also shown that at a molar ratio of 1: 500;
pyrene to lipid, the excimer fluorescence is at its lowest, consistent with being in
a non-aggregated state, within the membrane. Therefore changes in the flu-
orescence properties of PDA used at this molar ratio are likely to arise only from
the immediate environment surrounding it within the membrane. All these
factors highlight the usefulness of pyrene-labelled fatty acids and related probes
as ideal for the study of membranes, a point emphasised in detail by Lakowicz in
[31].2.1. The binding location of TBBPA within phospholipid bilayers
Briefly, DOPC prepared in Chloroform: Methanol (2: 1; v/v) mixture was
doped with either PDA (12-(1-Pyrenyl) dodecanoic acid), PHA (6-(1-Pyrenyl)
Hexanoic acid) or PyDOPE (1, 2 Dioleyl-sn-glycerol-3-phosphoethanolamine:
Pyrene labelled within the head group) at a molar ratio of 500: 1. These
fluorescent lipids will obviously have their pyrene group located at different
positions/depths within the bilayer when incorporated into the DOPC
membranes. Appropriate amounts of DOPC and the lipid fluorophores were
mixed together with TBBPA (prepared in methanol) and the mixture was dried
onto the sides of the flasks. The dried lipids, fluorophore and TBBPA were
then re-suspended in buffer (40 mM HEPES, 100 mM NaCl, 1 mM EGTA (pH
7.2), to give final concentrations of fluorophore and DOPC of 0.2 and 100 μM,
respectively; and [TBBPA] of between 0 and 80 μM). The Mixture was then
sonicated in a sonicating bath for about 20 min (to make multilamellar
liposomes) and incubated in the dark for about 2 h at 25 °C, prior to use.
Pyrene fluorescence was measured in a Perkin Elmer LS50B spectro-
fluorimeter by exciting at 342 nm and monitoring the emission intensity at
395 nm.
2.2. Analysis of fluorescence quenching of pyrene dodecanoic acid
(PDA) in DOPC bilayers by TBBPA to determine its partition
coefficient
The binding of hydrophobic molecules to phospholipid bilayer can be
investigated by employing fluorescence quenching methods. Jones and Lee [18]
showed that PDA binds strongly to phospholipid bilayer with the Pyrene group
located in the fatty acyl chain region of the bilayer; consequently, PDAwas used
as a probe for phospholipid bilayers.
DOPC and PDA (in a molar ratio of 500: 1) were mixed with TBBPA, dried
on to the sides of the flask and re-suspended in buffer as described above, to give
a final concentration of DOPC of 50, 100, 200 and 300 μM respectively in
separate preparations; and each of these lipid mixtures contained various
amounts of TBBPA (up to 200 μM). The mixtures were then incubated in the
dark for about 2 h at 25 °C, fluorescence excited at 342 nm and the monomer
emission intensity monitored at 395 nm.
2.3. Analysis of quenching data
The Stern–Volmer equation:
F0=F ¼ 1þ Ksv½Qm ð1Þ
can be employed to describe the fluorescence quenching of PDA in a
phospholipid bilayer, where Fo and F are the fluorescence intensities in the
absence and presence of a quencher, respectively; [Qm], the concentration of
quencher in the membrane (moles/Litre); and Ksv, the quenching constant.
In the partition model, the distribution of quencher between membrane and
aqueous phases is given by a partition coefficient, Kp, which is defined as:
Kp ¼ ½Qm=½Qa ð2Þ
where, [Qa] is the concentration of quencher in the aqueous phase (moles/Litre).
Since the total number of moles of quencher added equals the sum of
quencher in the aqueous and membrane phases,
VtQt ¼ VmQm þ VaQa ð3Þ
where Vt is the total volume; Vm and Va are the volumes of the membrane and
aqueous phases, respectively; and Qt is the total concentration of quencher
added.Quenching is therefore defined as:
F0=F ¼ 1:0þ ½KsvKpVtQt=½Va þ KpVm ð4Þ
vesicle density was taken as 1 g/ml in the calculation of Vm [21]. Following
Omann and Lakowicz [22], the volume fraction, αm of the membrane, can be
expressed as:
am ¼ Vm=Vt ð5Þ
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F0=F ¼ 1:0þ ½KsvKpQt=½Kpam þ ð1 amÞ ð6Þ
At any particular lipid concentration, αm, Kp and Ksv are all constant; and an
apparent quenching constant Kapp can be expressed as:
Kapp ¼ KsvKp=½Kpam þ ð1 amÞ ð7Þ
Therefore,
F0=F ¼ 1:0þ ½KappQt ð8Þ
a graph of Fo/F against Qt will be a straight line with the slope Kapp; and a plot
of 1/Kapp against αm will also be a straight line, with slope given by:
Slope ¼ ð1=KsvÞ  ð1=kpKsvÞ ð9Þ
and an intercept given by:
Intercept ¼ 1=kpKsv ð10Þ
thus,
Kp ¼ slope=intercept ð11Þ
And
1=Ksv ¼ slopeþ intercept: ð12Þ
2.4. The interaction of TBBPA with DPPC bilayers at temperatures
below and above the lipid phase transition temperature
DPPC and PDA were mixed with varying [TBBPA] (up to 20 μM), dried
onto the sides of the flask and re-suspended in buffer as described above, to give
a final concentration of PDA and DPPC; 0.2 μM and 100 μM, respectively. The
mixture was incubated in the dark for about 2 h at 28 °C (<Tm) and kept at this
temperature. In another similar preparation, mixture of PDA, DPPC and TBBPA
was incubated in the dark for about 2 h at 48 °C (>Tm) and also kept at this
temperature. Fluorescence was excited at 342 nm and the monomer emission
intensity was recorded at 395 nm. Fluorescence intensity was then monitored for
the two preparations, kept at these temperatures.
2.5. The effects of TBBPA on the membrane fluidity of DOPC
membranes
DOPC and DPH (Molar ratio of 100:1) were mixed, either with varying
concentrations of TBBPA or cholesterol (used as a control), dried onto the sides
of flasks and re-suspended in buffer as described above, to give a final
concentration of DOPC and DPH of 50 and 0.5 μM, respectively. The re-
suspended mixture was sonicated and used to prepare a multilamellar vesicle.
The membranes were then incubated in the dark for about 2 h at 25 °C. DPH
fluorescence was measured by exciting the samples at 360 nm and monitoring
the emission intensity at 430 nm, using the polarizing filter module of the Perkin
Elmer LS 50B spectrofluorimeter.
2.6. Monitoring the effect of TBBPA on DPPC fluidity at temperatures
below and above the lipid phase transition temperature
DPPC and DPH (Molar ratio of 100: 1) were mixed with varying
concentrations of TBBPA (0 to 50 μM), dried onto the sides of flasks and re-
suspended in buffer and treated as described above, to give a final concentration
of DPPC and DPH; 100 and 1 μM, respectively. DPH fluorescence polarization
was then monitored.
2.7. Effect of TBBPA on the lipid phase transition temperature of
dipalmitoyl phosphatidyl choline; (DPPC)
The alteration in the Tm of DPPC upon binding of TBBPAwas investigated
by employing differential scanning calorimetry (DSC).Calorimetry experiments were performed on a Micro-Cal Inc. VP-
Differential Scanning Calorimeter with a cell volume of 0.52 mL, interfaced
with a personal computer (IBM-compatible). Different concentrations of
TBBPA (0–50 μM) with 100 μM Phospholipid (DPPC) and scan rates of
60 °C/h were used. Before the measurements, multilamellar vesicle was
prepared in Chloroform: Methanol (2: 1; v/v) mixture and mixed with
appropriate concentrations of TBBPA. The Mixtures were dried onto the sides
of the flasks and re-suspended in buffer (20 mM HEPES/Tris pH 7.2, 100 mM
KCl, 5 mM MgSO4). The mixture was then sonicated in a sonicating bath for
about 20 min and incubated in the dark for about 2 h at 37 °C. The samples and
reference solutions were degassed by stirring at room temperature and carefully
loaded into the cells to avoid bubble formation. A constant pressure of 29.5 psi
was maintained to prevent bubble formation of the samples on heating. A
background scan, recorded with the buffer in both cells was subtracted from
each test scan. 7 to 10 scans for each of the mixtures were then performed and a
mean scan calculated. ORIGIN software package (Micro-Cal) was used for
baseline subtraction and determination of total enthalpy change for each of the
scans.
2.8. Membrane permeability studies
The quenching of calcein dye trapped in egg Phosphatidyl choline liposomes
by Co2+ was employed to monitor the effect of TBBPA on membrane
permeability, as described in detail by Longland et al. [23].
2.9. Effect of TBBPA on Lipid mixtures containing SPM, CHOL and
PC
In order to mimic the complex and heterogeneous composition of plasma
membranes found within mammalian cells, the binding of TBBPA to lipid
bilayers, containing various proportions of Sphingomyelin, Cholesterol, DPPC
and DOPC was used according to the protocol described by Pang et. al. [32],
such that a variety of lipid bilayer environments, ranging from only PC to
membranes highly enriched in cholesterol and SPM, could be tested [32]. Thus a
model membrane ternary system, containing three binary systems: CHOL/PC,
SPM/CHOL and SPM/PC, was used to simulate the heterogenous lipid
composition of plasma membrane, as well as lipid rafts and caveolae regions, in-
vitro [32]. The molar ratio of SPM-CHOL to PC was gradually increased to
simulate the transition from a liquid-disordered (ld) phase to a liquid-ordered
phase (lo) and in particular, to study the binding efficiency/enhancement of
TBBPA in various lipid phases which is thought to represent non-raft and raft-
like membrane domains, respectively.
Various concentrations of lipid mixtures (with molar ratio of SPM-CHOL :
DPPC-DOPC, ranging from 0 to 1.0) and PDAwere mixed with 20 μM TBBPA
in different preparations as described above (with the total lipid concentration
kept at 100 mM and PDA at 0.2 mM), dried to the side of the glass and re-
suspended in buffer. The mixture was sonicated and used to prepare a
multilamellar vesicle. The mixture was then incubated in the dark for about 2 h
at 37 °C and kept at this temperature. Fluorescence was excited at 342 nm, the
monomer emission intensity recorded at 395 nm and the excimer emission
intensity monitored at 480 nm.3. Results
In Fig. 1, three different pyrene-labelled lipids were
employed, a long chain (PDA), a shorter chain (PHA) pyrene-
fatty acid and PyDOPE (with the label, incorporated into the
head group). Using these different pyrene-labelled lipids, we can
effectively assess where TBBPA partitions within the phospho-
lipid bilayer, by observing its ability to quench the fluorescence
of these pyrene lipids. The results in Fig. 1 show that the degree
of fluorescence quenching of the different pyrene lipids by
TBBPA, are quite similar for all the three pyrene probes. This
result would indicate that TBBPA appears to be randomly
Fig. 2. (A) Fluorescence quenching (Fo/F) of PDA in DOPC liposomes at 25 °C,
pH 7.2 upon addition of TBBPA. Quenching was measured at DOPC liposome
concentrations of: 50 μM (▪); 100 μM (▴); 200 μM (▾); 300 μM (♦). The
molar ratio of PDA to Phospholipid in these experiments, was 1: 500. The data
values are the mean±SD of three determinations. The lines are simulations in
terms of the partition model described in the text. (B) Plot of 1/Kapp calculated
from the initial slopes of the lines in Fig. 2A against the membrane volume
fraction αm. From these data, the partition coefficient (Kp) for TBBPA binding to
phospholipids was calculated to be Log Kp of 5.7, Stern–Volmer constant (Ksv)
of 1.66 M−1.
Fig. 3. Fluorescence quenching (F/Fo) of PDA by TBBPA, in liposomes of
DPPC (16: 0), at a temperature below (▪) (28 °C) and above (▴) (48 °C) the
phase transition temperature. The DPPC phospholipid concentration used was
100 μM, in a buffer at pH 7.2. The data points are the mean±SD of three
determinations.
Fig. 1. Fluorescence quenching (F/Fo) of pyrene lipids; PHA (▪); PDA (▴); and
PyDOPE (▾) incorporated into DOPC liposomes (molar ratio 1: 500) at 25 °C;
pH 7.2, upon addition of TBBPA (0 to 80 μM). The DOPC Phospholipid
concentration in these experiments was 100 μM. Values are plotted as the mean±
SD of three or more determinations. Inset shows the position of the pyrene group
for the different pyrene-labelled lipids within the membrane.
1562 O.A. Ogunbayo et al. / Biochimica et Biophysica Acta 1768 (2007) 1559–1566distributed in both the hydrophobic fatty acyl-chain region and
in the polar region of the phospholipid bilayer near to the head
group. However, there appears to be a slight preponderance in
favour of the hydrophobic fatty-acyl region.
Pyrene dodecanoic acid (PDA) has been commonly
employed in this study as a probe for phospholipid bilayer,
since this has been shown to bind strongly to bilayer with the
Pyrene group positioned in the fatty acyl chain region of the
bilayer [18–20]. As shown, TBBPA efficiently quenched PDA
fluorescence. The extent of quenching at any given TBBPA
concentration, however, decreased with increasing concentra-
tion of phospholipids, as expected for the partitioning of
TBBPA to phospholipid bilayer. The straight line plots in Fig.
2A shows that there is no significant saturation of sites in the
bilayer over the concentration range of TBBPA used. As shown
in Fig. 2B, the data fits well to the partition model; and a plot of
1/Kapp derived from the initial gradients of the lines shown in
Fig. 2A against the volume fraction, αm, gives a value for the
Stern–Volmer constant: (Ksv) of 1.66±0.21 M
−1 and a partition
coefficient: (Kp) of 480,000 (Log Kp=5.7±0.7).
Fig. 3 shows the quenching of PDA within DPPC (16: 0)
liposomes at temperatures below (28 °C) and above (48 °C), the
Lipid phase transition temperature (Tm: 41.5 °C [24]). As shown
in Fig. 3, the degree of fluorescence quenching increased with
increasing TBBPA concentrations (0–20 μM) at temperatures
below and above the Tm. However, the degree of quenching is
slightly more pronounced when DPPC is in the rigid gel phase
(<Tm). This observation suggests that, TBBPA preferentially
binds to a more ordered/less mobile regions of the membrane.
In order to assess whether TBBPA can affect membrane
fluidity, the fluorescence polarization of DPH within DOPC
liposomes wasmeasured in the presence and absence of TBBPA.
Previous studies have shown that, decreases in membrane
Fig. 4. Fluorescence polarization of DPH in liposomes of DOPC (18:1) at 25 °C,
pH 7.2; in the presence of cholesterol (▪) and TBBPA (▴) at a DOPC
phospholipid concentration of 100 μM. The data values are the mean±SD of
three determinations.
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bilayer, causes an increase in DPH fluorescence polarization
[25]. In Fig. 4, it can be seen that cholesterol which decreases the
fluidity of phospholipid bilayers when in liquid-crystalline
phase, causes a substantial increase in DPH fluorescence
polarization. A comparable increase in polarization is observed
when TBBPA, over a similar concentration range, is added to
DOPC liposomes. The data in Fig. 4 also shows that, significant
effects on fluorescence polarization of DOPCmembranes can be
observed at concentrations of TBBPA as low as 5 μM and
therefore indicates that, low concentrations of TBBPA can
substantially reduce membrane fluidity.
Fig. 5 shows the effect of TBBPA on DPPC fluidity
(monitored by increases in DPH fluorescence polarization) at
temperatures below (23 °C) and above (45 °C), the phase
transition temperature. It shows that the addition of TBBPA to
DPPC bilayer at 23 °C (when it will be in the gel-phase) results in
an increase in fluorescence polarization of DPH in the bilayer,
which appears more substantial than that observed at 45 °C
(when it will be in the liquid-crystalline phase). This suggests
that TBBPA tends to further decrease the fluidity of the gel-Fig. 5. Fluorescence polarization of DPH in liposomes of DPPC at temperatures,
below (23 °C) (▪) and above (45 °C) (▴) the phase transition temperature, in
the presence TBBPA (0–40 μM) at phospholipid concentration of 100 μM. The
data values are the mean±SD of three determinations.phase membrane, as well as decreasing the fluidity of
membranes in the liquid-crystalline phase. Again, differences
in fluidity were observed at TBBPA concentrations as low as
2.5 μM.
The data obtained in Fig. 6A using DSC showed that, a large
endothermic event corresponding to the phase transition (Tm) of
pure DPPC liposomes occurred at 41.19±0.02 °C (consistent
with previously published values for DPPC [24]). These data
also showed that, upon the addition of TBBPA (from 10 to
50 μM), the Tm was lowered by about 2 °C (Fig. 6B). The
profiles showed that there is both a reduction in the rate of
enthalpy change with temperature upon addition of TBBPA, as
well as a broadening of the phase transition temperature. TheseFig. 6. Shows the binding effect of TBBPA on the Tm of DPPC, at a
phospholipid concentration of 100 μM, pH 7.2, measured using DSC (▴). The
values represent the mean Tm±SD calculated from 7 to 10 scans.
Table 1
The effects of TBBPA on membrane permeability as assessed by the rate of
calcein fluorescence quenching, entrapped within egg PC liposomes, upon
addition of TBBPA
[TBBPA] (μM) Initial rate of quenching (%ΔF/min)
0 13.8
10 8.8
50 2.4
Fig. 7. (A) Shows the effect of 20 μM TBBPA on the fluorescence intensity of
PDA in various molar ratios of SPM-CHOL/DPPC-DOPC liposomes. The ratio
of SPM/CHOL was kept at 1: 2 (mol). Experiments were carried out at 25 °C
and fluorescence monitored at the monomer emission wavelength of 395 nm.
(B) Shows the effect of 20 μM TBBPA on the fluorescence intensity of PDA in
various molar ratios of SPM-CHOL/DPPC-DOPC liposomes. The ratio of SPM/
CHOL was kept at 1: 2 (mol). Experiments were carried out at 25 °C and
fluorescence monitored at the excimer emission wavelength of 480 nm. The data
points represent the mean±SD of 3 or more determinations.
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cholesterol [24].
Experiments employing Co2+ to measure the rate of
quenching of calcein entrapped within liposomes (as originally
described by Oku et al. [26]) were performed in order to assess
the effects of TBBPA on membrane permeability. As observed
in Table 1, there is a substantial rate of calcein fluorescence
quenching by Co2+ within the egg PC liposomes in the absence
of TBBPA. However, upon addition of 10 μM TBBPA, the
initial rate of calcein quenching decreased by 36%, while at
50 μM TBBPA, the initial rate of quenching was dramatically
reduced by about 83%.
Although the monomer emission intensity of PDA fluores-
cence was not appreciably altered at the lower SPM-Chol/
DPPC-DOPC molar ratio (i.e. corresponding to 0 to 20%
Cholesterol in the membrane mixture), this fluorescence was
slightly increased as the mole ratio of SPM-Chol/DPPC-DOPC
was increased above a value of 0.6 (corresponding to 25% or
greater of cholesterol in the membrane mixture) (Fig. 7A). In
order to assess whether the above data was an artifact due to the
PDA probe aggregating within specific regions of the hetero-
geneous membrane, the excimer fluorescence was also
monitored. As shown in Fig. 7B, no appreciable fluorescence
change of PDA in bilayers was observed in the presence of
20 μM TBBPA, at the excimer emission wavelength of 480 nm,
as the bilayer composition was altered by the addition of
Cholesterol and sphingomyelin. This implies that there was no
significant aggregation of PDA as the lipid composition is
varied, and as such the PDA monomer fluorescence intensity
will accurately reflect its immediate lipid environment. These
results would therefore indicate that the binding of TBBPA to
membranes highly enriched in cholesterol is slightly less
favourable than in membranes containing ≤20% cholesterol
and therefore TBBPA would more likely partition into regions
of the plasma membrane which are not raft-like.
4. Discussion
The hydrophobic nature of TBBPA would suggest that, it
will bind extensively to phospholipid bilayers, supporting
previous reports which suggests that its cytotoxic site of action
might be at (or involve) the biological membrane [11–13,15–
17]. Although, estimates of oil or octanol/water partition
coefficient (Kp) for TBBPA can be made, the values obtained
are, at best, only a crude approximation to the actual Kp that
might be found for phospholipid membranes.
Halogen-induced fluorescence quenching of membrane
bound probes has been extensively used over the years, toyield information on membrane/drug interactions [18–20,31].
As this type of quenching requires close contact between the
halogen and the fluorophore, this technique can be used to
determine relative locations of the halogen and the fluorophore
within membranes [27]. Since fortuitously TBBPA contains
bromines within its structure, this property has been exploited to
study its interaction with phospholipid membranes.
The binding of fluorescence quenching hydrophobic mole-
cules to phospholipid bilayers, can be quantified from an
analysis of the fluorescence quenching ability of a suitable
fluorophore incorporated into themembrane. Pyrene dodecanoic
acid (PDA [C-12]) and other pyrene-labelled fatty acids have
been shown to be suitable probes for such studies [18–20,31].
These studies show that the pyrene group orients itself within the
fatty-acyl hydrophobic core of the bilayer, while being anchored
by the carboxyl-end to the glycerol backbone region of the
bilayer. As such, different chain length pyrene-labelled fatty
acids (with the pyrene group attached at the opposite end to the
carboxyl group) can be used as probes, to assess the depth
location of the quenching hydrophobic molecule (Fig. 1 inset).
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[C-6], PDA and pyrene-labelled DOPE in phospholipid bilayers
(Fig. 1) shows that TBBPA distributes throughout all regions of
the phospholipid bilayer, but slightly favouring the hydrophobic
core.
Again, using the fluorescence quenching properties of
membrane bound pyrene fluorophores, we have directly
measured the partition coefficient of TBBPA to phospholipid
bilayers made from DOPC and shown it to have a Log Kp of
5.7. This is considerably higher than the binding of hydrophobic
molecules like bromo-sterols and bromine containing pyre-
throid insecticides to phospholipid membranes, measured using
a similar approach [19,20]. Table 2 shows for comparison the
oct/water Log Kp values for a number of other aromatic
endocrine disrupters, bromo-phenols and brominated flame
retardants. As can be seen, Log Kp for TBBPA determined here,
is considerably higher than that of bisphenol A. However, as the
addition of bromines to phenol greatly increases its Log Kp by
several orders, this could easily account for the difference.
Other known aromatic endocrine disrupters such as nonylphe-
nol [28], Bis-(2-ethyhexyl)-phtalate, and butylated hydroxyto-
luene all have similar Log Kp values to TBBPA, while p,p′-
DDT and another BFR hexabromocyclododecane have higher
values.
Binding of TBBPA to phospholipid bilayers seems to be
affected by the physical state of the bilayer, with a relatively
better binding occurring in the gel phase than in the liquid
crystalline phase. Furthermore, measurements of Fluorescence
polarization of DPH shows that, the addition of TBBPA to a
phospholipid bilayer in the liquid-crystalline state, results in an
increase in polarization and consequently, a decrease in fluidity,
comparable to that seen upon addition of cholesterol (Fig. 4).
Thus, this study has shown that, TBBPA tends to rigidify both
fluid-phase and gel-phase bilayer using DPPC membranes,
above and below the Tm, and it can alter the physical state of
phospholipid bilayer, by lowering its Tm. The decrease in
fluidity of liquid-crystalline membranes (DPPC above the Tm)
can be readily explained by TBBPA acting in a manner similar
to that for cholesterol, intercalating between the fatty-acyl
chains of the phospholipids and thus, restricting their motion.
The decrease in fluidity of the already rigid gel phase DPPCTable 2
The oct/water Log Kp values for molecules related to TBBPA
Compound Oct/water Log Kp
Bisphenol A 3.3
Phenol 1.5
Bromophenol 3.0
Pentabromophenol 6.0
Nonylphenol 5.5
BHT 5.1
Bis-(2-ethyhexyl)phtalate 5.0
DDT 6.4
Hexabromocyclododecane 7.6
All values were obtained from international occupational safety and health
information centre (CIS) website: http://www.ilo.org/public/english/protection/
safework/cis/products/icsc/dtasht/index.htm.(<Tm), is not so easy to explain. However, since it is known that
even in gel-phase, lipid membranes exhibit a degree of
deformation resulting from the occurrence of vacancies and
defects or distortions in the lattice structure [24,25] and DPH
might preferentially partition into these vacancies. To some
extent therefore, the polarization of DPH molecules might not
accurately monitor the mobility of bulk phospholipid mem-
branes, but rather, the mobility of lipids within these slightly
less restricted regions. If these less restricted regions within gel-
phase membranes also preferentially bind TBBPA, it will cause
the DPH within them to become much more restricted, thus,
increasing its polarization value.
Many important proteins have been reported to be
dynamically associated with caveolae/raft domains in plasma
membranes, possibly due to the fact that rafts promote specific
protein–protein interactions, which are essential for cellular
processes such as intracellular trafficking and signal transduc-
tion [33]. In this study, we investigated the binding behavior of
TBBPA in the lo phase (created, by the addition of cholesterol
and SPM, in order to mimic artificially, the caveolae/raft-like
domain of the membrane). Our results indicate that TBBPA
prefers to bind slightly more favourably to membranes which
have lower proportions of cholesterol and sphingomyelin (i.e.
not completely raft-like membrane regions). This finding
appears to be in contrast with earlier findings in this study
where TBBPA favours binding to rigid gel phase phospholipid
bilayers. Although, the precise mechanism of interaction among
PC, SPM and CHOL; and the characterization of their dynamics
were not investigated, our observation may possibly be due to
reduced collision between the fluorophore (PDA) and the
quencher (TBBPA) in the lo state, due to specific stearic
hindrance, effected by the intercalation of cholesterol, within
the bilayer, limiting TBBPA binding in these regions.
Our results would indicate that TBBPA has a profound effect
upon the fluidity, mobility and packing of phospholipid mem-
branes, irrespective of whether the membrane is in a gel- or
liquid-crystalline phase. One consequence of this can be ob-
served by the fact that when TBBPA is incorporated into phos-
pholipid membranes, they become less permeable to metal ions.
As a decrease in membrane fluidity corresponds to an
increase membrane viscosity [29], this will likely have the effect
of slowing down the rates of any biological process which
involves rate-limitingmembrane associated steps [29,30]. As the
toxicological properties of TBBPA occur in the low mM
concentration range [15–17], and as we can observe changes in
membrane fluidity at TBBPA concentrations as low as 2.5 μM,
we suggest that toxic effects of TBBPA, may at least in part, be
due to its membrane perturbing effects.
In summary, this study was undertaken to investigate the
effects of brominated fire retardant, Tetrabromobisphenol A
(TBBPA), on phospholipid bilayers and has shown that it
distributes throughout the whole phospholipid bilayer, binding
to the membrane with high efficacy and altering the membranes
biophysical properties. Perturbations in phospholipid mem-
branes caused by TBBPA, among others, include increasing
membrane packing/viscosity and consequently, reducing mem-
brane permeability to ions. These effects may contribute to the
1566 O.A. Ogunbayo et al. / Biochimica et Biophysica Acta 1768 (2007) 1559–1566toxicological effects of TBBPA, by modulating biological
processes involving the cell membrane.
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